Phase I / II, multicenter, randomized and controlled clinical trial to assess the safety and efficacy of intravenous administration of expanded Allogeneic Adipose Tissue Adult Mesenchymal Stem cells in patients with severe pneumonia due to COVID-19

  • Funded by Centro Regulador de Urgencias y Emergencias (CRUE Santander)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $169,500
  • Funder

    Centro Regulador de Urgencias y Emergencias (CRUE Santander)
  • Principal Investigator

    N/A

  • Research Location

    Spain
  • Lead Research Institution

    Universidad de Sevilla
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract